Nathan Slaughter

Nathan Slaughter, Chief Investment Strategist of The Daily Paycheck and High-Yield Investing, has developed a long and successful track record over the years by finding profitable investments no matter where they hide. Nathan's previous experience includes a long tenure at AXA/Equitable Advisors, one of the world's largest financial planning firms. He also honed his research skills at Morgan Keegan, where he managed millions in portfolio assets and performed consultative retirement planning services. To reach more investors, Nathan switched gears in 2004 and began writing full-time. He has since published hundreds of articles for a variety of prominent online and print publications. Nathan has interviewed industry insiders like Paul Weisbruch and CEOs like Tom Evans of Bankrate.com, and has been quoted in the Los Angeles Times for his expertise on economic moats. Nathan's educational background includes NASD Series 6, 7, 63, & 65 certifications, as well as a degree in Finance/Investment Management from Sam M. Walton School of Business, where he received a full academic scholarship. When not following the market, Nathan enjoys watching his favorite baseball team, the Cubs, and camping and fishing with his family.

Analyst Articles

We interrupt this regularly scheduled publication to bring you a breaking news bulletin. Originally, I had planned to discuss the ramifications of last week’s mid-term elections with my Daily Paycheck subscribers. But there is plenty of time to get to that in the weeks ahead. For now, I’ll just say that gridlock in Congress is often advantageous for investors. And we’ll be seeing plenty of that over the next two years. Instead, I want to steer your attention to some important news that’s been somewhat ignored amid the election news and the volatile overall market. I’m talking about what’s happening… Read More

We interrupt this regularly scheduled publication to bring you a breaking news bulletin. Originally, I had planned to discuss the ramifications of last week’s mid-term elections with my Daily Paycheck subscribers. But there is plenty of time to get to that in the weeks ahead. For now, I’ll just say that gridlock in Congress is often advantageous for investors. And we’ll be seeing plenty of that over the next two years. Instead, I want to steer your attention to some important news that’s been somewhat ignored amid the election news and the volatile overall market. I’m talking about what’s happening with the price of oil. —Recommended Link— The F.U.S.I.O.N. Profit System: If you’re tired of investing in stocks that go nowhere, then you need to read this. Come see what may be the single BIGGEST BREAKTHROUGH the investment world has ever seen. The Bear Market Nobody Is Talking About Benchmark crude oil prices dropped for 12 consecutive trading sessions, the longest such streak on record, according to Dow Jones. You’d think that major shifts in sentiment for such a massive global market would take weeks or months to play out, not days. Supply/demand fundamentals can’t turn on a… Read More

The market is now well into a second month of higher volatility and declining prices. And if you feel that the recent volatility impacted our portfolio stocks disproportionally, you are correct. Our stocks, many of which have been market champions on the way up,… Read More

Growing up during the anti-drug hysteria of the Reagan era, the “Just Say No” mantra was firmly planted in my psych. It wasn’t just the hard drugs that were vilified, but even the mild counter-cultural favorite of cannabis was believed to be destructive. Thought of as a “gateway drug” to life-ruining addiction, severe prison penalties were imposed for its use, possession, and sale. —Recommended Link— New Retirement Solution: ‘Executive Dividends’ Issued by some of the biggest corporations in America but unreported by the press, these “Executive Dividends” can be worth a fortune–if you know where to look… See how… Read More

Growing up during the anti-drug hysteria of the Reagan era, the “Just Say No” mantra was firmly planted in my psych. It wasn’t just the hard drugs that were vilified, but even the mild counter-cultural favorite of cannabis was believed to be destructive. Thought of as a “gateway drug” to life-ruining addiction, severe prison penalties were imposed for its use, possession, and sale. —Recommended Link— New Retirement Solution: ‘Executive Dividends’ Issued by some of the biggest corporations in America but unreported by the press, these “Executive Dividends” can be worth a fortune–if you know where to look… See how to cash in HERE, starting at $3,080 per month. Despite the aggressive anti-drug publicity campaign, William Buckley, the voice of noted conservatives, and others cried out for decriminalization of most recreational drugs. Even though I am not a recreational weed smoker, their rhetoric made sense to me. I started to see through the draconian national drug policy thus understanding the need for decriminalization. As it turns out, Buckley and the rest of the early decriminalization advocates were way ahead of the curve. Today, the once evil substance of cannabis is legal in about a dozen states and decriminalized in more. Not… Read More

There is a world of difference between investors and traders. In general, investors use fundamental analysis to research and buy stocks at the head of some secular trend. Investors only sell stocks once the investment thesis undergirding that trend is exhausted. And to give a stock the time needed for a thesis to materialize, investors typically hold on to their stocks for years — and even decades. —Recommended Link— THE LIST: Top 7 Growth Stocks To Buy Now Our annual research has produced winners of 310%, 452%, and even 569% in years past. Last year’s picks are beating the… Read More

There is a world of difference between investors and traders. In general, investors use fundamental analysis to research and buy stocks at the head of some secular trend. Investors only sell stocks once the investment thesis undergirding that trend is exhausted. And to give a stock the time needed for a thesis to materialize, investors typically hold on to their stocks for years — and even decades. —Recommended Link— THE LIST: Top 7 Growth Stocks To Buy Now Our annual research has produced winners of 310%, 452%, and even 569% in years past. Last year’s picks are beating the S&P 500 3-to-1. And this year’s report could be the most profitable yet… If you’re tired of paltry gains, then this could be the most important thing you read all year. Click here to see it. During this time, investors boost their profits by taking advantage of occasional stock splits and dividend reinvesting, or compounding. Compounding allows investors to purchase additional shares of stock with no further capital outlay. The resulting increase in the number of shares owned from stock splits and compounding significantly lowers an investment’s cost basis over time. Traders Think Differently Traders are much more aggressive… Read More

What a violent October we had in the market. And if that weren’t enough, we had the election to contend with to kick off November. —Recommended Link— “It’s like getting 26 paychecks advanced to you in ONE LUMP SUM!” Executive Dividends are one of Wall Street’s best-kept secrets, paying out a small fortune in unannounced cash seemingly at random–and today, Nathan Slaughter shows you where to find them. Read more here. Now that it’s all behind us, I hope neither of those things distracted you from what matters at least as much (perhaps more) — which is taking the… Read More

What a violent October we had in the market. And if that weren’t enough, we had the election to contend with to kick off November. —Recommended Link— “It’s like getting 26 paychecks advanced to you in ONE LUMP SUM!” Executive Dividends are one of Wall Street’s best-kept secrets, paying out a small fortune in unannounced cash seemingly at random–and today, Nathan Slaughter shows you where to find them. Read more here. Now that it’s all behind us, I hope neither of those things distracted you from what matters at least as much (perhaps more) — which is taking the long view on your portfolio. For my Fast-Track Millionaire subscribers and myself, that means doing the hard work of watching developments in the market’s fastest growing sectors and digging deeper to find ideas that can dramatically alter the trajectory of our portfolio. Take biotech for instance. This is an area that would have been easy to completely ignore during all the chaos and volatility of the past six weeks or so. But not us. Risk vs. Reward Biotechnology is risky, and so is investing in it. #-ad_banner-#These risks can be managed, but they can also be compounded. An example… Read More

One year ago, Bitcoin and other cryptocurrencies were in the middle of a monstrous bull run. A single Bitcoin surged close to $20,000 as the rest of the market followed to dizzying heights. Millionaires were minted in untold numbers as Lamborghini dealers and other luxury merchants reaped the rewards of the mostly young and brash nouveau riche. Just like our forefathers’ 1920s and 1980s, this period was indeed our generation’s hyper-energized Shangri-La of wealth creation. What a phenomenal time to be alive! —Recommended Link— THE LIST: Top 7 Growth Stocks To Buy Now Our annual research has produced winners… Read More

One year ago, Bitcoin and other cryptocurrencies were in the middle of a monstrous bull run. A single Bitcoin surged close to $20,000 as the rest of the market followed to dizzying heights. Millionaires were minted in untold numbers as Lamborghini dealers and other luxury merchants reaped the rewards of the mostly young and brash nouveau riche. Just like our forefathers’ 1920s and 1980s, this period was indeed our generation’s hyper-energized Shangri-La of wealth creation. What a phenomenal time to be alive! —Recommended Link— THE LIST: Top 7 Growth Stocks To Buy Now Our annual research has produced winners of 310%, 452%, and even 569% in years past. Last year’s picks are beating the S&P 500 3-to-1. And this year’s report could be the most profitable yet… If you’re tired of paltry gains, then this could be the most important thing you read all year. Click here to see it. Then It All Came Crashing Down… Since this heady season, the market has suffered a massive reversal of fortune as prices plunged lower during 2018. The leading player, Bitcoin, gave back over 1/3 of its value while many newly-minted junk coins simply vanished. The less popular cryptos plunged… Read More

Remember the elation when the Dow Jones Industrial Average first hit 20,000? It happened in January 2017, not that long ago really. Since then, the venerable benchmark blew through 21,000, 22,000, 23,000, 24,000, and 25,000. After a powerful run like that, you can expect many stocks to be overvalued. —Recommended Link— The Only Pot Stock Worth Owning This summer, Canada will completely legalize cannabis for medical and recreational use — sparking an $8 BILLION industry.  Our experts have their sights on a company that’s been granted a virtual monopoly by the Canadian government – a moat that would make… Read More

Remember the elation when the Dow Jones Industrial Average first hit 20,000? It happened in January 2017, not that long ago really. Since then, the venerable benchmark blew through 21,000, 22,000, 23,000, 24,000, and 25,000. After a powerful run like that, you can expect many stocks to be overvalued. —Recommended Link— The Only Pot Stock Worth Owning This summer, Canada will completely legalize cannabis for medical and recreational use — sparking an $8 BILLION industry.  Our experts have their sights on a company that’s been granted a virtual monopoly by the Canadian government – a moat that would make Warren Buffett jealous. Get in early on this exceptional triple-digit opportunity before the law goes into effect. Click here to learn more. And indeed, many are. The S&P 500 is currently trading at 15.6 times forward earnings. While not excessive, that’s a sizeable premium to the historical 10-year average of 14.5. According to Morningstar, the average U.S. stock is priced at 102% of its fair value — and that’s after the October swoon. Nobody goes to a car dealership (or anywhere else) looking to pay 2% above sticker price. Not only do current valuations limit the upside, but as we’ve… Read More

  Last month, I ran a stock screen to see which companies seemed attractive to insiders in the month of September, with the market trading near its all-time highs. You can see it here. One stock from that screen, E. W. Scripps (Nasdaq: SSP), has already… Read More

A big disappointment came today from one of our Fast Revenue Growers portfolio holdings, internet marketer and insurance quote provider EverQuote (Nasdaq: EVER). The company’s quarterly guidance — which, for this young company, is the best way we have to judge whether or not… Read More